Table 3.
Vessel Density in U87 Tumors After SU5416 and Dalteparin.
Treatment Group | N Fields Counted | Chalkley Counts | t-test Compared with Controls | |
Mean Counts/Field |
SD | |||
Controls | 50 | 5.1 | 1.6 | |
SU5416 | 40 | 5.1 | 1.9 | NS |
Dalteparin | 50 | 4.8 | 1.7 | NS |
SU5416+dalteparin | 40 | 5.5 | 2.1 | NS |
NS= no significant difference.